Related Experiment Video
Updated: Jul 5, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery
Michael Rossiter-Thornton1, Viswanath Arun, A Paul Forrest
1Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia.
Abstract:
We report the first Australian use of the Impella LP 5.0, a minimally invasive, high-output left ventricular assist device. The device was inserted intra-operatively for cardiac failure following coronary artery grafting. Although it facilitated a temporary post-operative recovery, the patient ultimately succumbed due to left ventricular failure more than 30 days after the original procedure. This device has several advantages over existing forms of left ventricular support, and has the potential for widespread use in Australian centres.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
